Live tape
Top 8, mentions 7d6,876GOOGL1,548 mentions▲ +0.03NKE1,352 mentions▲ +0.03META1,009 mentions▲ +0.05NVDA881 mentions▲ +0.09TSLA603 mentions▲ +0.05MSFT502 mentions▲ +0.04AMZN492 mentions▲ +0.06AAPL489 mentions▲ +0.06

Equity · Consumer Defensive

BGS

NYSE

B&G Foods, Inc.

$2.87 −6.51% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 30, 2026
Price · Chart
Our own end-of-day closes 62 sessions
$4.5 $2.5 6 Jul 30 Sep

The line runs $4 on 6 July through $2.87 on 30 September, on a scale from $2.5 to $4.5. Days the market did not trade hold the previous close, flat.

The chart above plots the price of BGS over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $4 on 6 July 2026 through $2.87 on 30 September 2026.

Market cap $233.3M
52-week range $2.87 – $5.89
Avg volume 120.7K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 30, 2026

BGS insider trades

SEC Form 4 · last 90 days · newest reported trade 14 Sep 2026
Open-market buys 1
Open-market sells 0
Net bought $18K
Non-trade filings 1
Date Insider Type Shares Value
14 Sep 2026 Brunts DeAnn L Director Buy 5,616 $18K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
10 Aug 2026 Mills Robert D President & CEO Award 134,408

BGS reported financials

SEC EDGAR XBRL

BGS reported revenue of $1.8B for the fiscal year ended 03 Jan 2026. Net income over the same period was −$43.3M.

Figure Reported Period
Revenue $1.8B 03 Jan 2026 fiscal year
Net income −$43.3M 03 Jan 2026 fiscal year
Diluted EPS −$0.54 03 Jan 2026 fiscal year
Total assets $3.4B 04 Jul 2026 at period end
Total equity $395.1M 04 Jul 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 04 Jul 2026

BGS earnings

SEC EDGAR
Date Period EPS Revenue
04 Jul 2026 Q2 2026 $-0.05 $383M
04 Apr 2026 Q1 2026 $-0.41 $409M
03 Jan 2026 FY 2026 $-0.54 $1.83B
27 Sep 2025 Q3 2025 $-0.24 $439M
28 Jun 2025 Q2 2025 $-0.12 $424M
29 Mar 2025 Q1 2025 $0.01 $425M
28 Dec 2024 FY 2024 $-3.18 $1.93B
28 Sep 2024 Q3 2024 $0.09 $461M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

BGS institutional holders

SEC Form 13F

6 of the 45 institutional funds we track reported a BGS position for the quarter ended 30 Jun 2026 — a combined $9.6M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
AQR Capital Management Trimmed −29.8% shares 876,786 $3.5M
Two Sigma Investments Trimmed −77.1% shares 738,207 $2.9M
Millennium Management Added +1,342.0% shares 314,188 $1.3M
Marshall Wace Trimmed −25.7% shares 292,216 $1.2M
Citadel Advisors Added +561.8% shares 119,362 $475K
Renaissance Technologies Trimmed −81.6% shares 77,400 $308K

Source: SEC EDGAR 13F filings

BGS fails-to-deliver

SEC CNS data

On 14 Sep 2026, 108,696 shares of BGS failed to deliver (about $342K) — the latest of 5 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
14 Sep 2026 108,696 $342K 0.134%
11 Sep 2026 85,030 $274K 0.105%
10 Sep 2026 86,231 $280K 0.106%
09 Sep 2026 100,091 $330K 0.123%
08 Sep 2026 36,732 $121K 0.045%
02 Sep 2026 3,568 $12K 0.004%
28 Aug 2026 20,237 $70K 0.025%
27 Aug 2026 1,515 $5K 0.002%
26 Aug 2026 23,603 $83K 0.029%
24 Aug 2026 4 $14 <0.001%
21 Aug 2026 644 $2K 0.001%
20 Aug 2026 5,028 $18K 0.006%
19 Aug 2026 14,725 $51K 0.018%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in BGS

STOCK Act disclosures

The most recent congressional trade disclosed in BGS is a sale by David J. Taylor (house, OH), dated 25 Mar 2019.

Date Member Type Amount
25 Mar 2019 filed 15 Apr 2019 David J. Taylor house · Republican–OH Sale $1K–$15K

Source: U.S. House of Representatives financial disclosures